Brief: Medicus Pharma Announces Filing Of FDA Commissioner’s National Priority Voucher Application (Cnpv) For Sknjct-003 To Non-Invasively Treat Basal Cell Carcinoma (Bcc) Of The Skin
17/11/2025 12:35
Nov 17 (Reuters) - Medicus Pharma Ltd MDCX.O: MEDICUS PHARMA LTD. ANNOUNCES FILING OF FDA COMMISSIONER’S NATIONAL PRIORITY VOUCHER APPLICATION (CNPV) FOR SKNJCT-003 TO NON-INVASIVELY TREAT BASAL CELL CARCINOMA (BCC) OF THE SKIN Source text: ID:nGNX8DChYb Further company coverage: MDCX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicus Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Medicus Pharma Submits Optimized Teverelix® Registrational Protocol To FDA To Create Partner Ready Program In Advanced Prostate Cancer